Close Menu

Keep an Eye Out

With the constant innovation and development happening in the biotech and technology centers, it's hard to keep up with everything, says David DiSalvo at the Forbes Neuropsyched column. To help keep things straight, DiSalvo lists some of the developments he thinks are worth looking out for. In medicine, both stem cell heart generation and hybrid MRI/PET imaging are on DiSalvo's list.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.